JAC Advance Access originally published online on January 13, 2005
Journal of Antimicrobial Chemotherapy 2005 55(2):229-233; doi:10.1093/jac/dkh538
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JAC vol.55 no.2 © The British Society for Antimicrobial Chemotherapy 2005; all rights reserved
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature
1 I Division of Infectious Diseases, D. Cotugno Hospital, Naples 2 Department of Infectious Diseases, II University of Naples, Naples 3 Department of Parasitology, Istituto Superiore di Sanità, Rome, Italy
* Corresponding author. Tel: +39-081-5908292; Fax: +39-081-5908300; Email: ppagliano{at}libero.it
Objectives:
Visceral leishmaniasis (VL) is endemic in tropical and sub-tropical areas. Only anecdotal cases of VL in pregnancy are reported in the literature, although the disease is life-threatening for both mothers and infants. Here we report a small series of pregnant women with VL observed in the Neapolitan area over a 7 year period and carry out a systematic review of the literature on this topic.
Methods:
Consecutive cases of VL in HIV-negative female patients between 1996 and 2002 were evaluated. Pregnant women who fulfilled criteria for VL diagnosis were included and diagnostic, clinical and therapeutic features were considered. The outcome for both the pregnant woman and the fetus was evaluated over a 24 month period of post-therapy follow-up. A systematic search of English language literature through the MEDLINE database and Cochrane Library with the search strings ‘leishmaniasis AND pregnancy’ and ‘leishmaniasis AND visceral AND congenital’ integrated with a manual search completed our study.
Results:
Five consecutive pregnant women were diagnosed as having VL. Fever and hepatosplenomegaly were the main presenting symptoms. All received liposomal amphotericin B without any toxicity to either the mothers or newborns. No treatment failure or congenital VL case was observed. The systemic review of the literature revealed 17 cases of VL during pregnancy. Untreated VL resulted in consequences on the fetus or congenital VL.
Conclusions:
The efficacy and safety of amphotericin B formulations for mother and fetus are supported by the cumulative analysis of our data and literature data.
Keywords: therapy , antimonials , amphotericin B
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Osorio, D. L. Bonilla, A. G. Peniche, P. C. Melby, and B. L. Travi Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production J. Leukoc. Biol., June 1, 2008; 83(6): 1413 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mueller, M. Balasegaram, Y. Koummuki, K. Ritmeijer, M. R. Santana, and R. Davidson A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan J. Antimicrob. Chemother., October 1, 2006; 58(4): 811 - 815. [Abstract] [Full Text] [PDF]
|
|